Cytosorbents (CTSO) Change in Accured Expenses (2010 - 2026)
Cytosorbents' (CTSO) quarterly Change in Accured Expenses came in at $92000.0 in Q1 2026, up 125.07% YoY from $40876.5 in Q1 2025, and up 117.07% on a QoQ basis from -$539000.0 in Q4 2025.
Cytosorbents (CTSO) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Change in Accured Expenses data on file, last reported at $92000.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 125.07% year-over-year to $92000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$247000.0 (up 72.35% YoY) and the FY2025 annual result came in at -$706000.0, up 60.95% from the prior year.
- Change in Accured Expenses improved to $92000.0 in Q1 2026, from -$539000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.4 million in Q4 2024 to a low of -$1.3 million in Q1 2024.
- A 5-year average of -$239036.0 and a median of -$338765.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses sank 490.9% — and 2023, when it surged 371.1%.
- Tracing CTSO's Change in Accured Expenses over 5 years: stood at -$206441.0 in 2022, then jumped by 371.1% to $559666.0 in 2023, then surged by 142.64% to $1.4 million in 2024, then sank by 139.69% to -$539000.0 in 2025, then soared by 117.07% to $92000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $92000.0 (Q1 2026), -$539000.0 (Q4 2025), and $193000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Cytosorbents | 21.41 Mn | 17.00 Mn | 7.05 Mn | 221,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 221,000.00 |
| Jun 30, 2026 | 221,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | -539,000.00 |
| Dec 31, 2025 | -539,000.00 |
| Sep 30, 2025 | 193,000.00 |
| Sep 30, 2025 | 193,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | -367,000.00 |
| Mar 31, 2025 | -367,000.00 |
| Dec 31, 2024 | 1.36 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -750,276.00 |
| Jun 30, 2024 | -750,276.00 |
| Mar 31, 2024 | -1.28 Mn |
| Mar 31, 2024 | -1.28 Mn |